DK0741565T3 - Fremgangsmåde til fremstilling af S(+)-ibuprofenpartikler - Google Patents

Fremgangsmåde til fremstilling af S(+)-ibuprofenpartikler

Info

Publication number
DK0741565T3
DK0741565T3 DK95906207T DK95906207T DK0741565T3 DK 0741565 T3 DK0741565 T3 DK 0741565T3 DK 95906207 T DK95906207 T DK 95906207T DK 95906207 T DK95906207 T DK 95906207T DK 0741565 T3 DK0741565 T3 DK 0741565T3
Authority
DK
Denmark
Prior art keywords
pct
ibuprofen
particles
tablets
sec
Prior art date
Application number
DK95906207T
Other languages
English (en)
Inventor
Gerhard Hantich
Ernst Hesse
Torsten Moeller
Original Assignee
Gebro Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gebro Pharma Gmbh filed Critical Gebro Pharma Gmbh
Application granted granted Critical
Publication of DK0741565T3 publication Critical patent/DK0741565T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1688Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polyurethanes Or Polyureas (AREA)
DK95906207T 1994-01-28 1995-01-26 Fremgangsmåde til fremstilling af S(+)-ibuprofenpartikler DK0741565T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0015894A AT401871B (de) 1994-01-28 1994-01-28 Verfahren zur herstellung von s(+)-ibuprofen- partikeln mit verbesserten fliesseigenschaften und deren verwendung zur arzneimittelherstellung
PCT/AT1995/000014 WO1995020382A1 (de) 1994-01-28 1995-01-26 Verfahren zur herstellung von s(+)-ibuprofen-partikeln

Publications (1)

Publication Number Publication Date
DK0741565T3 true DK0741565T3 (da) 2000-09-04

Family

ID=3483086

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95906207T DK0741565T3 (da) 1994-01-28 1995-01-26 Fremgangsmåde til fremstilling af S(+)-ibuprofenpartikler

Country Status (20)

Country Link
US (1) US5869101A (da)
EP (1) EP0741565B1 (da)
JP (1) JP2840132B2 (da)
AT (2) AT401871B (da)
AU (1) AU689531B2 (da)
CA (1) CA2181810C (da)
CZ (1) CZ287998B6 (da)
DE (1) DE59508198D1 (da)
DK (1) DK0741565T3 (da)
ES (1) ES2146744T3 (da)
FI (1) FI112030B (da)
GR (1) GR3033841T3 (da)
HU (1) HU217798B (da)
NO (1) NO313982B1 (da)
NZ (1) NZ278551A (da)
PL (1) PL179095B1 (da)
PT (1) PT741565E (da)
SI (1) SI9520030A (da)
SK (1) SK282433B6 (da)
WO (1) WO1995020382A1 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI225402B (en) 1996-03-13 2004-12-21 Biochemie Gmbh Auxiliary-free agglomerates
GB9613470D0 (en) * 1996-06-27 1996-08-28 Ciba Geigy Ag Small solid oral dosage form
IT1301966B1 (it) 1998-07-30 2000-07-20 Zambon Spa Composizioni farmaceutiche ad attivita' analgesica
CA2364342C (en) 1999-04-01 2011-02-01 Dsm N.V. Agglomerates by crystallisation
DK1235558T3 (da) * 1999-12-09 2006-10-09 Reckitt Benckiser Healthcare Sammenpresset tabletsammensætning, der omfatter et NSAID
KR100700721B1 (ko) * 2000-09-08 2007-03-27 지상철 안정성 및 용출율이 향상된 s(+)-이부프로펜의 정제
GB0113839D0 (en) * 2001-06-07 2001-08-01 Boots Co Plc Therapeutic agents
CN1889931A (zh) * 2003-12-04 2007-01-03 辉瑞产品公司 利用挤压器制备优选含泊洛沙姆和甘油酯的多重粒子阿奇霉素组合物的喷雾-冻凝方法
ATE399536T1 (de) * 2003-12-04 2008-07-15 Pfizer Prod Inc Verfahren zur herstellung von pharmazeutischen multiteilchenförmigen produkten
US6984403B2 (en) * 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
BRPI0416534A (pt) * 2003-12-04 2007-01-09 Pfizer Prod Inc composições multiparticuladas com estabilidade melhorada
EP1694304A2 (en) * 2003-12-04 2006-08-30 Pfizer Products Inc. Azithromycin multiparticulate dosage forms by liquid-based processes
WO2005053652A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
WO2005053639A2 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Controlled release multiparticulates formed with dissolution enhancers
CA2549225A1 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Spray-congeal process using an extruder for preparing multiparticulate crystalline drug compositions containing preferably a poloxamer and a glyceride
CZ297830B6 (cs) * 2005-08-30 2007-04-11 I.Q.A., A. S. Zpusob výroby jemne krystalické smesi obsahující nesteroidní protizánetlivé lécivo, jemne krystalická smes pripravitelná tímto zpusobem a pevný farmaceutický prostredek tuto smes obsahující
CN105963259A (zh) * 2016-05-25 2016-09-28 山东理工大学 一种采用常压过滤制备布洛芬微球的方法
CN109956860B (zh) * 2019-03-08 2022-03-01 天津大学 一种布洛芬球形晶体的制备方法
CN110041191A (zh) * 2019-04-30 2019-07-23 湖南九典宏阳制药有限公司 一种培比洛芬的纯化方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4086346A (en) * 1974-04-06 1978-04-25 Bayer Aktiengesellschaft Preparation of melt-sprayed spherical phenacetin granules
JPS52111533A (en) * 1976-03-12 1977-09-19 Kanebo Ltd Preparation of fine powder of ibuprophene
US4476248A (en) * 1983-02-28 1984-10-09 The Upjohn Company Crystallization of ibuprofen
US4609675A (en) * 1984-08-17 1986-09-02 The Upjohn Company Stable, high dose, high bulk density ibuprofen granulations for tablet and capsule manufacturing
ATE50493T1 (de) * 1986-11-14 1990-03-15 Puetter Medice Chem Pharm Ibuprofen enthaltendes arzneimittel.
GB8716975D0 (en) * 1987-07-17 1987-08-26 Boots Co Plc Therapeutic agents
US5198568A (en) * 1988-04-07 1993-03-30 Sepracor, Inc. Compounds useful in enzymatic resolution systems and their preparation
DE3833446A1 (de) * 1988-10-01 1990-04-05 Hoechst Ag Verfahren zur herstellung von arzneimittelwirkstoff-partikeln mit verbesserten fliess-, lager- und formulierungseigenschaften sowie arzneimittel, die diese arzneimittelwirkstoff-partikeln enthalten
DE3833448A1 (de) * 1988-10-01 1990-04-12 Hoechst Ag Verfahren zur gewinnung von ibuprofen fuer die direkttablettierung
HU209603B (en) * 1988-10-05 1994-09-28 Upjohn Co Process for production of solid powders in finalydivided microcristallin form
JPH082781B2 (ja) * 1988-10-18 1996-01-17 嘉明 川島 中空顆粒状医薬及びその製法
US5104656A (en) * 1989-06-16 1992-04-14 Seth Pyare L Percutaneous treatment with a high potency non-steroidal anti-inflammatory agent
DE69108044T2 (de) * 1990-11-19 1995-07-06 Albemarle Corp Verfahren zur verbesserung der fliessencharakteristik von kristallinem ibuprofen.
DE4122591C1 (en) * 1991-07-08 1993-02-18 Roland 8012 Ottobrunn De Bodmeier Producing microcapsules of water insoluble polymer and active agent - includes dissolving or dispersing active agent in aq. polymer contg. gellable assistants
US5191114A (en) * 1991-10-09 1993-03-02 Sage Pharmaceuticals, Inc. Process for enhancing the flow characteristics of ibuprofen
DE4140179C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Akutform für ein Ibuprofen enthaltendes Arzneimittel

Also Published As

Publication number Publication date
CZ213196A3 (en) 1996-10-16
US5869101A (en) 1999-02-09
NO962966L (no) 1996-07-15
FI112030B (fi) 2003-10-31
PL315655A1 (en) 1996-11-25
PL179095B1 (pl) 2000-07-31
SI9520030A (en) 1996-12-31
DE59508198D1 (de) 2000-05-25
EP0741565B1 (de) 2000-04-19
NO313982B1 (no) 2003-01-13
GR3033841T3 (en) 2000-10-31
CZ287998B6 (cs) 2001-03-14
AT401871B (de) 1996-12-27
CA2181810C (en) 2000-10-24
ES2146744T3 (es) 2000-08-16
ATA15894A (de) 1996-05-15
WO1995020382A1 (de) 1995-08-03
SK96496A3 (en) 1997-01-08
NZ278551A (en) 1997-10-24
EP0741565A1 (de) 1996-11-13
JPH09503522A (ja) 1997-04-08
HU9602013D0 (en) 1996-09-30
NO962966D0 (no) 1996-07-15
FI962866L (fi) 1996-07-16
ATE191848T1 (de) 2000-05-15
JP2840132B2 (ja) 1998-12-24
SK282433B6 (sk) 2002-02-05
HUT74853A (en) 1997-02-28
AU1449995A (en) 1995-08-15
AU689531B2 (en) 1998-04-02
PT741565E (pt) 2000-09-29
HU217798B (hu) 2000-04-28
FI962866A0 (fi) 1996-07-16

Similar Documents

Publication Publication Date Title
DK0741565T3 (da) Fremgangsmåde til fremstilling af S(+)-ibuprofenpartikler
DK0675710T3 (da) Fremgangsmåde til fremstilling af farmaceutiske former med styret frigivelse samt de herved opnåede former
PT703779E (pt) Tabletes que contem enzimas e processos para a sua preparacao
PL312739A1 (en) New derivatives of perhydro isoindole, their production and pharmaceutical compounds containing them
DE69904954D1 (de) Verfahren zur herstellung neuer fenofibrathaltiger arzneiformulierungen, dadurch hergestellte arzneiformulierungen und ihre verwendung
IL116385A0 (en) Sulphonamides their manufacture and pharmaceutical compositions containing them
DK0532611T3 (da) Fremgangsmåde til fremstilling af porøse cellulosematrixer
DK0789559T4 (da) Farmaceutisk præparat indeholdende en smeltelig bærer og en fremgangsmåde til fremstilling deraf
NO983575L (no) FremgangsmÕte for Õ fremstille tabletter inneholdende erytritol
HU9602896D0 (en) Tobacco products, or substances similar to such products, containing natural substances with anti-oxidant properties, and process for producing the same
IL114598A (en) Triazole compounds their preparation and pharmaceutical compositions containing them
DE69102707D1 (de) In einem DNA - Gel stabilisierte Heilwasserliposomen.
Lv et al. Effect of orange peel essential oil on oxidative stress in AOM animals
DK0725813T3 (da) Anvendelse af detergentblandinger til fremstilling af toiletopfriskningsblokke
KR950031043A (ko) 열 과립화 방법
DE69415018D1 (de) Oralanzuwendende flüssige arzneizubereitung enthaltend 2-(4-isobutylphenyl)propionsäure
IL103005A0 (en) Process for producing pharmaceutical compositions
DE69320356D1 (de) Feste planzenschutzmittel-formulierung
DE59608511D1 (de) Verfahren zur herstellung von schichttabletten zur kontrollierten freisetzung von wirkstoffen
DK0557389T3 (da) Fremgangsmåde til fremstilling af tabletter indeholdende cephalosporansyrederivater ved direkte komprimering
FR2404517A1 (fr) Procede pour la fabrication de produits bruts en forme de plaque pour realiser des pieces faconnees
JPS5376463A (en) Crushing method of quickly cooled and solidified powder
ATE170527T1 (de) Phosphonobernsteinsäurederivate und ihre verwendung als arzneimittel
ES2117958B1 (es) Coagulante para leche extraido de cynara cardunculus, procedimiento para su preparacion y sus aplicaciones.
BG104156A (en) Method for the preparation of 2-diethylaminoethylisothiouronium chloride hydrochloride